CVRX INC (CVRX) Stock Overview
NASDAQ:CVRX - US1266381052 - Common Stock
CVRX Key Statistics, Chart & Performance
The current stock price of CVRX is 7.56 USD. In the past month the price decreased by -8.47%. In the past year, price decreased by -23.33%.
CVRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.83 | 228.80B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.53 | 168.90B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.41 | 156.87B | ||
| SYK | STRYKER CORP | 30.6 | 150.31B | ||
| MDT | MEDTRONIC PLC | 16.65 | 117.94B | ||
| BDX | BECTON DICKINSON AND CO | 13.69 | 56.01B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.48 | 47.50B | ||
| RMD | RESMED INC | 29.52 | 41.28B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.90B | ||
| DXCM | DEXCOM INC | 44.93 | 29.95B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.58 | 26.66B |
Related stock screener links
About CVRX
Company Profile
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.
Company Info
CVRX INC
9201 West Broadway Avenue, Suite 650
Minneapolis MINNESOTA US
CEO: Nadim Yared
Employees: 206
Phone: 17634162850
CVRX INC / CVRX FAQ
What is the stock price of CVRX INC today?
The current stock price of CVRX is 7.56 USD. The price decreased by -0.26% in the last trading session.
What is the ticker symbol for CVRX INC stock?
The exchange symbol of CVRX INC is CVRX and it is listed on the Nasdaq exchange.
On which exchange is CVRX stock listed?
CVRX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CVRX INC stock?
13 analysts have analysed CVRX and the average price target is 11.83 USD. This implies a price increase of 56.51% is expected in the next year compared to the current price of 7.56. Check the CVRX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CVRX INC worth?
CVRX INC (CVRX) has a market capitalization of 197.69M USD. This makes CVRX a Micro Cap stock.
How many employees does CVRX INC have?
CVRX INC (CVRX) currently has 206 employees.
What are the support and resistance levels for CVRX INC (CVRX) stock?
CVRX INC (CVRX) has a support level at 7.43 and a resistance level at 7.59. Check the full technical report for a detailed analysis of CVRX support and resistance levels.
Is CVRX INC (CVRX) expected to grow?
The Revenue of CVRX INC (CVRX) is expected to grow by 9.98% in the next year. Check the estimates tab for more information on the CVRX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CVRX INC (CVRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CVRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CVRX, evaluating the profitability, health, valuation and growth aspects
- CVRX INC (CVRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CVRX INC (CVRX) Sales and EPS estimates to see what analysts future expectations are.
- CVRX INC (CVRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CVRX INC (CVRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- CVRX INC (CVRX) Stock Chart to make your own analysis
- CVRX INC (CVRX) Latest news and press-releases to stay up to date.
Does CVRX INC (CVRX) stock pay dividends?
CVRX does not pay a dividend.
When does CVRX INC (CVRX) report earnings?
CVRX INC (CVRX) will report earnings on 2025-10-27, after the market close.
What is the Price/Earnings (PE) ratio of CVRX INC (CVRX)?
CVRX INC (CVRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.1).
What is the Short Interest ratio of CVRX INC (CVRX) stock?
The outstanding short interest for CVRX INC (CVRX) is 8.32% of its float. Check the ownership tab for more information on the CVRX short interest.
CVRX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CVRX. When comparing the yearly performance of all stocks, CVRX is a bad performer in the overall market: 78.25% of all stocks are doing better.
CVRX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CVRX. Both the profitability and financial health of CVRX have multiple concerns.
CVRX Financial Highlights
Over the last trailing twelve months CVRX reported a non-GAAP Earnings per Share(EPS) of -2.1. The EPS increased by 17.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.7% | ||
| ROE | -90.19% | ||
| Debt/Equity | 0.85 |
CVRX Forecast & Estimates
13 analysts have analysed CVRX and the average price target is 11.83 USD. This implies a price increase of 56.51% is expected in the next year compared to the current price of 7.56.
For the next year, analysts expect an EPS growth of 23.03% and a revenue growth 9.98% for CVRX